Stay updated on CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page
- Check7 days agoChange DetectedAdds a MedlinePlus Genetics related topics section to the page. It includes a link for Rheumatoid arthritis to broaden related educational resources.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page’s topics/related topics section was updated by removing the core disease tag 'Rheumatoid arthritis' and the related resource entry 'MedlinePlus Genetics' (along with the related topics header), altering how the study is categorized and connected to external health resources.SummaryDifference0.2%

- Check22 days agoChange DetectedRevision: v3.5.4 has been added, replacing the previous revision label v3.5.3. This reflects a site version update without altering substantive study information.SummaryDifference0.1%

- Check29 days agoChange DetectedThe related topics section no longer lists 'Rheumatoid arthritis' or the 'MedlinePlus Genetics' link, reducing disease-specific context and related resources on the page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page’s displayed revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a change to the site build rather than the study record.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.